
Pfizer Inc.
PFE 25.85 (0.31%) 0.08
Health Care
Pharmaceuticals
Quality Checklist 3/8
Debt/Equity < 1
Current Ratio > 1
Net Margin > 10%
5Y Shares Out Change < 0%
ROIC > 10%
Quick Ratio > 1
Past Net Income CAGR > 0%
Est. EPS Growth > 5%
0.0%of Portfolio
My holdings
Day change:
Total change:
Shares:Cost basis:
Market cap: $146.98(B)
EV: $196.07(B)
Total Equity: $93.10(B)
Earnings date: Feb-03-2026
P/E: 14.94
Forward P/E: 8.23
P/FCF: 14.20
P/S: 2.34
P/B: 1.58
EPS: $1.7
EPS (fwd): $3.1
FCF/share: $1.8
Revenue/share: $11.1
Book value/share: $16.3
ROIC: 6.3%
ROA: 4.6%
ROE: 10.6%
Debt/Equity: 0.67
Current Ratio: 1.30
Gross margin: 74.8%
Operating margin: 24.6%
Net margin: 15.7%
Dividend/share: $1.7
Div. yield: 6.58%
Growth Estimates
Revenue
CAGR: -3.6%FY+1$62.54(B)
FY+2(-1.2%)$61.81(B)
FY+3(-3.2%)$59.82(B)
FY+4(-5.4%)$56.58(B)
FY+5(-4.7%)$53.93(B)
Net Income
CAGR: -6.8%FY+1$18.01(B)
FY+2(-2.2%)$17.62(B)
FY+3(-3.1%)$17.07(B)
FY+4(-11.1%)$15.18(B)
FY+5(-10.4%)$13.60(B)
EPS
CAGR: -6.8%FY+1$3.14
FY+2(-1.6%)$3.09
FY+3(-3.2%)$2.99
FY+4(-11.7%)$2.64
FY+5(-10.2%)$2.37
FCF per share
CAGR: -0.7%FY+1$2.96
FY+2(+15.6%)$3.42
FY+3(-3.7%)$3.29
FY+4(-6.6%)$3.08
FY+5(-6.3%)$2.88
